Last reviewed · How we verify
NCT05725668
A Study of Dual-task Exercise Training to Prevent Falls Among Older Adults With Mild Cognitive Impairment
NA trial testing dual-task tai ji quan in Mild Cognitive Impairment in 336 participants. Currently enrolling.
30 July 2027
Quick facts
| Lead sponsor | Oregon Research Institute |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 336 |
| Start date | 15 July 2023 |
| Primary completion | 30 July 2027 |
| Estimated completion | 31 January 2028 |
| Sites | 1 location across United States |
Drugs / interventions tested
- dual-task tai ji quan
- standard tai ji quan
- stretching
Conditions studied
- Mild Cognitive Impairment — all drugs for Mild Cognitive Impairment →
- Accidental Falls — all drugs for Accidental Falls →
- Aging — all drugs for Aging →
Sponsor
Oregon Research Institute
Who can join
Adults 65 to 95, any sex, with Mild Cognitive Impairment or Accidental Falls. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To determine the efficacy of a dual-task tai ji quan training therapy in reducing the incidence of falls in older adults with mild cognitive impairment.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The Science of Tai Chi and <i>Qigong</i> as Whole Person Health-Part I: Rationale and State of the Science.
Wayne PM, Ahn A, Clark J, Irwin MR, et al · · 2025 · cited 5× · PMID 40091656 · DOI 10.1089/jicm.2024.0957
Verify or expand the search:
- PubMed search for NCT05725668
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Mild Cognitive Impairment
Currently open trials in the same condition.
- NCT05791994 — EVASION: Effect of VisuAl Stimulation on attentION · NA · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07220694 — Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairmen · NA · recruiting
- NCT06983769 — CPAP vs MAD for OSA in Patients With Cognitive Impairment. A Randomized Clinical Trial · NA · recruiting
- NCT07318038 — The Use of Rhythmic Light Therapy in Mild Cognitive Impairment · NA · recruiting
Other Oregon Research Institute trials
Trials by the same sponsor.
- NCT06306287 — Adolescent Screening and Personalized Intervention Resource for Enhancement of Behavioral Health and Substance Use · NA · recruiting
- NCT05822466 — Virtual Tai ji Quan Exercise to Prevent Falls in Older Adults · NA · recruiting
- NCT05437809 — Biobehavioral Reward Responses Associated With Consumption of Nutritionally Diverse Ultra-Processed Foods · NA · recruiting
- NCT05142384 — ICBT (Internet Based Cognitive Behavioral Therapy) for Maternal Depression: Community Implementation in Head Start · NA · recruiting
- NCT04923230 — Pilot Test of Parent-Focused Cannabis-Related Actions and Practices Intervention for Adolescent Marijuana Abuse · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05725668 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Oregon Research Institute
- Last refreshed: 17 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05725668.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing